Use this button to switch between dark and light mode.

FDA Clinical Hold Orders

December 17, 2024 (1 min read)

This practice note discusses clinical hold orders issued by the U.S. Food and Drug Administration (FDA) to sponsors of investigational new drug (IND) applications, including grounds for issuing a clinical hold order, how the FDA issues an order, and how a sponsor should respond to a clinical hold order to ensure a timely review.

Read now »


Related Content

Practical Guidance Updates
Featuring the latest updates from your Practical Guidance account.

  • For Practical Guidance content on important recent trends, review easy-to-use Resource Kits on these emerging topics:
  • Document alerts allow you to stay current on legal developments that affect your practice. Find out how to set up your document alerts.
  • The Practical Guidance Journal features guidance on the use of AI in employment decisions, AI considerations in acquisition agreements, Chevron deference reversal challenges in FDA rulemaking, 50 years of ERISA pension protection, plus obligations and risks related to the provision of anti-overdose medication in the workplace.
  • Legal Developments provide the latest updates and analyses of emerging topics impacting your practice area. Visit the Legal Developments page to see the latest topics, which also include breaking legal news and related Practical Guidance content.
  • Browse the Practical Guidance Author Center to see the 2000+ leading attorney authors contributing to our 26 practice areas. Interested in becoming a Practical Guidance author? Click here for details. Practical Guidance is committed to amplifying diverse voices of attorneys across all differences, including gender and race.

PRACTICAL GUIDANCE CUSTOMER EMAIL EDITION ON THE WEB

Experience results today with practical guidance, legal research, and data-driven insights—all in one place.

Experience Lexis+